NCT07677514: A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
- State
- Not started
- Phase
- Phase 2
- People
- 156 planned
- Started
- 12 Jul 2026
- Primary completion
- 12 Oct 2026
- Arms
- H021 Enteric-coated Tablets High-dose Group
- Results
- None posted
- 30 Jun 2026: Trial registered